Semenogelin, the main protein of the human semen coagulum, regulates sperm function

被引:103
作者
de Lamirande, Eve [1 ]
机构
[1] McGill Univ, Royal Victoria Hosp, Fac Med, Urol Res Lab, Montreal, PQ H3A 1A1, Canada
关键词
semenogelin; prostate specific antigen; sperm motility; sperm capacitation; semen coagulum;
D O I
10.1055/s-2006-958463
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Semenogelin (Sg), the main component of the human semen coagulum, is an important and versatile protein acting on several sperm parameters, both as intact or degraded Sg. Sg originates mostly from seminal vesicle and probably is responsible for sperm immobilization in the seminal coagulum. Purified Sg can be cross-linked by transglutaminase or phosphorylated by kinases, but the actual occurrence of these reactions in reproductive physiology is not clear. Experimental evidence demonstrates that prostate-specific antigen (PSA) rapidly cleaves Sg, an event temporally associated with semen liquefaction and initiation of sperm motility. Sg and its degradation peptides participate in various processes including Zn+2 shuttling, antibacterial activity, hyaluronidase activation, and so on. Sg inhibits sperm motility at the concentration found in the coagulum, but the rapid processing by PSA allows initiation of movement. The mechanism of Sg action and its targets are not known, but improper Sg degradation decreases fertility. Sg and its degradation peptides block sperm capacitation and associated events at concentrations much lower than those of seminal plasma and could play important role in preventing premature capacitation. The effects of Sg are dependent on time and proteolysis due to PSA, and any imbalance may affect sperm physiology and fertility.
引用
收藏
页码:60 / 68
页数:9
相关论文
共 47 条
[1]  
Aitken RJ, 1998, J CELL SCI, V111, P645
[2]   ROLE OF ZINC DURING HAMSTER SPERM CAPACITATION [J].
ANDREWS, JC ;
NOLAN, JP ;
HAMMERSTEDT, RH ;
BAVISTER, BD .
BIOLOGY OF REPRODUCTION, 1994, 51 (06) :1238-1247
[3]   SPECIES-SPECIFICITY AND ORGAN-SPECIFICITY OF SECRETORY PROTEINS DERIVED FROM HUMAN PROSTATE AND SEMINAL-VESICLES [J].
AUMULLER, G ;
SEITZ, J ;
LILJA, H ;
ABRAHAMSSON, PA ;
VONDERKAMMER, H ;
SCHEIT, KH .
PROSTATE, 1990, 17 (01) :31-40
[4]   Biology of prostate-specific antigen [J].
Balk, SP ;
Ko, YJ ;
Bubley, GJ .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (02) :383-391
[5]  
Bjartell A, 1996, J ANDROL, V17, P17
[6]   Involvement of semenogelin-derived peptides in the antibacterial activity of human seminal plasma [J].
Bourgeon, F ;
Evrard, B ;
Brillard-Bourdet, M ;
Colleu, D ;
Jégou, B ;
Pineau, C .
BIOLOGY OF REPRODUCTION, 2004, 70 (03) :768-774
[7]   Amidolytic activity of prostatic acid phosphatase on human semenogelins and semenogelin-derived synthetic substrates [J].
Brillard-Bourdet, M ;
Réhault, S ;
Juliano, L ;
Ferrer, M ;
Moreau, T ;
Gauthier, F .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2002, 269 (01) :390-395
[8]   Glycodelin-S in human seminal plasma reduces cholesterol efflux and inhibits capacitation of spermatozoa [J].
Chiu, PCN ;
Chung, MK ;
Tsang, HY ;
Koistinen, R ;
Koistinen, H ;
Seppala, M ;
Lee, KF ;
Yeung, WSB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (27) :25580-25589
[9]  
Cormier N, 1997, J ANDROL, V18, P461
[10]   Biological basis for human capacitation [J].
De Jonge, C .
HUMAN REPRODUCTION UPDATE, 2005, 11 (03) :205-214